Charles A. Reinhart Iii.
Chief Financial Officer, Altimmune, Inc.
Companies
- Pacira BioSciences, Inc.Chief financial officer May 4, 2016 to Jun 13, 20241
- Osiris TherapeuticsBoard member Sep 17, 2018 to Sep 17, 20182
- Altimmune, Inc.Chief financial officer Aug 24, 2009 to Dec 10, 20103
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Pacira BioSciences, Inc. PCRX51,867 shares4$1.9M at $36.36Jun 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2024Granted 12,220 shares of Pacira BioSciences, Inc.4
- Jun 3, 2024Shares withheld for tax 2,979 shares at $30.89 of Pacira BioSciences, Inc.5
- Jun 14, 2023Granted 9,000 shares of Pacira BioSciences, Inc.6
- Jun 7, 2023Sold 1,371 shares at $37.87 of Pacira BioSciences, Inc.7
- Jun 6, 2023Sold 1,236 shares at $38.99 of Pacira BioSciences, Inc.7
- Jun 8, 2022Granted 7,950 shares of Pacira BioSciences, Inc.8
- Jun 6, 2022Sold 2,516 shares at $61.37 of Pacira BioSciences, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAROsiris Therapeutics, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 5, 2024
- 6SEC EDGARForm 4 filed Jun 16, 2023
- 7SEC EDGARForm 4 filed Jun 7, 2023
- 8SEC EDGARForm 4 filed Jun 8, 2022